Milestones in ataxia
- 27 May 2011
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 26 (6), 1134-1141
- https://doi.org/10.1002/mds.23559
Abstract
The past 25 years have seen enormous progress in the deciphering of the genetic and molecular basis of ataxias, resulting in improved understanding of their pathogenesis. The most significant milestones during this period were the cloning of the genes associated with the common spinocerebellar ataxias, ataxia telangiectasia, and Friedreich ataxia. To date, the causative mutations of more than 30 spinocerebellar ataxias and 20 recessive ataxias have been identified. In addition, there are numerous acquired ataxias with defined molecular causes, so that the entire number of distinct ataxia disorders exceeds 50 and possibly approaches 100. Despite this enormous heterogeneity, a few recurrent pathophysiological themes stand out. These include protein aggregation, failure of protein homeostasis, perturbations in ion channel function, defects in DNA repair, and mitochondrial dysfunction. The clinical phenotypes of the most common ataxia disorders have been firmly established, and their natural history is being studied in ongoing large observational trials. Effective therapies for ataxias are still lacking. However, novel drug targets are under investigation, and it is expected that there will be an increasing number of therapeutic trials in ataxia. © 2011 Movement Disorder SocietyKeywords
This publication has 46 references indexed in Scilit:
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondThe Lancet Neurology, 2010
- RNA‐mediated neurodegeneration in repeat expansion disordersAnnals of Neurology, 2010
- Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3Brain, 2009
- Physiologic Alterations in AtaxiaArchives of Neurology, 2009
- Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patientsBrain, 2009
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3Journal of Neuroscience, 2008
- Polyglutamine neurodegeneration: protein misfolding revisitedTrends in Neurosciences, 2008
- Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1Nature, 2008
- Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse ModelPLoS Medicine, 2007
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004